Defibrotide for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: A Concordance Analysis Between Day+100 Complete Response and Survival by Richardson, Paul G., MD, Riches, Marcie L., MD, Kernan, Nancy A., MD, Brochstein, Joel A., MD, Mineishi, Shin, MD, Termuhlen, Amanda M., MD, Arai, Sally, MD, Grupp, Stephan A., MD, PhD, Miloslavsky, Maja, PhD, Nejadnik, Bijan, MD, Hannah, Alison L., MD, Soiffer, Robert J., MD

Get full text

Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled,... by Richardson, Paul G., MD, Kernan, Nancy A., MD, Brochstein, Joel A., MD, Mineishi, Shin, MD, Arai, Sally, MD, Grupp, Stephan A., MD, PhD, Guinan, Eva, MD, Martin, Paul L., MD, PhD, Steinbach, Gideon, MD, PhD, Krishnan, Amrita, MD, Nemecek, Eneida R., MD, Duerst, Reggie E., MD, Antin, Joseph H., MD, Lehmann, Leslie, MD, Gillio, Alfred P., MD, Bajwa, Rajinder, MBBS, MRCP, MD, Miloslavsky, Maja, PhD, Hume, Robin, MS, Iacobelli, Massimo, Nejadnik, Bijan, MD, Hannah, Alison L., MD, Soiffer, Robert J., MD

Get full text

Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of “Late” Alemtuzumab by Jain, Akshat, MD, Sahdev, Indira, MD, Brochstein, Joel, MD, Werther, Nan, RN, MS, CPNP

Get full text